Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Riabi, Samira ^a,b   Harrath, Rafik ^a,b   Gaaloul, Imed ^a   Bouslama, Lamjed ^c   Nasri, Dorsaf ^b   Aouni, Mahjoub ^a   Pillet, Sylvie ^d   Pozzetto, Bruno ^b,d  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITÉ DE LYON   (France)

^c CENTRE DE BIOTECHNOLOGIE DE BORJ CÉDRIA   (Tunisia)

^d UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

CaCo 2 cell line; CV B; Phenotypes; Receptors; TEER; Variants

Indexed keywords

AMINO ACID; ANTIBODY; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DECAY ACCELERATING FACTOR; LIGAND; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR LIKE MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; ASSAY; CACO 2 CELL LINE; COXSACKIE VIRUS B; GENE SEQUENCE; GENETIC ANALYSIS; GENOME; HUMAN; HUMAN CELL; INFECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPE; VIROGENESIS; VIRUS; VIRUS ISOLATION; VIRUS STRAIN; ANIMAL; CHO CELL LINE; CRICETULUS; ENTEROVIRUS; ENTEROVIRUS INFECTION; GENETICS; HAMSTER; HELA CELL LINE; METABOLISM; PATHOGENICITY; SEROTYPING; VIROLOGY;

ADENOVIRIDAE; COXSACKIEVIRUS; HUMAN ENTEROVIRUS B;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD55; CACO-2 CELLS; CHO CELLS; COXSACKIE AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN; CRICETINAE; CRICETULUS; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; HELA CELLS; HUMANS; LIGANDS; SEROTYPING;

EID: 84901689769     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-21-50     Document Type: Article

References (46)

1. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R, PNAS USA 1992 89 314 318 10.1073/pnas.89.1.314 1309611
2. Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Klingel K, Rieger P, Mall G, Selinka HC, Huber M, Kandolf R, Lab Invest 1998 78 1227 1237 9800948 (Pubitemid 28491696)
3. Is juvenile diabetes a viral disease? Fohlman J, Friman G, Ann Med 1993 25 569 574 8292308 (Pubitemid 24027011)
4. Genomic and phylogenetic characterization of coxsackievirus B2 prototype strain Ohio-1. Polacek C, Lundgren A, Andersson A, Lindberg AM, Virus Res 1999 59 229 238 10.1016/S0168-1702(98)00140-3 10082394 (Pubitemid 29078649)
5. Picornaviridae: The Viruses and Their Replication. Rueckert RR, Fields Virology Philadelphia: Lippincott-Raven Publishers, Fields BM, Knipe DM, Howley PM, 3 1996 609 654
6. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance. Rossmann MG, J Biol Chem 1989 264 14587 14590 2670920 (Pubitemid 19237265)
7. Structure of a human common cold virus and functional relationship to other picornaviruses. Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, Hecht HJ, Johnson JE, Kamer G, Luo M, Mosser AG, Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, Hecht HJ, Johnson JE, Kamer G, Luo M, Mosser AG, Rueckert RR, Sherry B, Vriend G, Nature (London) 1985 317 145 153 10.1038/317145a0 2993920 (Pubitemid 16243130)
8. The canyon hypothesis. Rossmann MG, Viral Immunol 1989 2 143 161 10.1089/vim.1989.2.143 2560913 (Pubitemid 19275648)
9. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, Kuhn RJ, Anderson CW, Freimuth P, Rossmann MG, Nat Struct Biol 2001 8 874 878 10.1038/nsb1001-874 11573093 (Pubitemid 32923607)
10. Transmembrane proteins in the tight junction barrier. Fanning AS, Mitic LL, Anderson JM, J Am Soc Nephrol 1999 10 1337 1345 10361874 (Pubitemid 29247001)
11. The coxsackie-adenovirus receptor-a new receptor in the immunoglobulin family involved in cell adhesion. Philipson L, Pettersson RF, Curr Top Microbiol Immunol 2004 273 87 111 14674599 (Pubitemid 37209896)
12. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells. Polacek C, Ekstrom JO, Lundgren A, Lindberg AM, Virus Res 2005 113 107 115 10.1016/j.virusres.2005.04.021 15964091 (Pubitemid 41330766)
13. Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. Shieh JT, Bergelson JM, J Virol 2002 76 9474 9480 10.1128/JVI.76.18.9474-9480.2002 12186929 (Pubitemid 34919904)
14. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM, Proc Natl Acad Sci U S A 2001 98 15191 15196 10.1073/pnas. 261452898 11734628 (Pubitemid 34013991)
15. Inhibition of Coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. Goodfellow IG, Evans DJ, Blom AM, Kerrigan D, Miners JS, Morgan BP, Spiller OB, J Virol 2005 79 12016 12024 10.1128/JVI.79.18.12016- 12024.2005 16140777 (Pubitemid 41279318)
16. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD, J Virol 1995 69 3873 3877 7538177
17. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW, J Virol 1995 69 1903 1906 7531780
18. Interaction of decay-accelerating factor with coxsackievirus B3. Hafenstein S, Bowman VD, Chipman PR, Bator Kelly CM, Lin F, Medof ME, Rossmann MG, J Virol 2007 81 23 12927 12935 10.1128/JVI.00931-07 17804498 (Pubitemid 350156930)
19. Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A. Williams P, Chaudhry Y, Goodfellow IG, Billington J, Powell R, Spiller OB, Evans DJ, Lea S, J Biol Chem 2003 278 10691 10696 10.1074/jbc.M212561200 12499389 (Pubitemid 36800339)
20. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Bergelson JM, Chan M, Solomon KR, St. John NF, Lin H, Finberg RW, Proc Natl Acad Sci U S A 1994 91 6245 6249 10.1073/pnas.91.13.6245 7517044 (Pubitemid 24188320)
21. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). Karnauchow TM, Tolson DL, Harrison BA, Altman E, Lublin DM, Dimock K, J Virol 1996 70 5143 5152 8764022 (Pubitemid 26240685)
22. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule-1 for cell entry. Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD, J Virol 1997 71 4736 4743 9151867 (Pubitemid 27204166)
23. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW, J Infect Dis 1997 175 697 700 10.1093/infdis/175.3.697 9041347 (Pubitemid 27086179)
24. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW, Science 1997 275 1320 1323 10.1126/science.275.5304.1320 9036860 (Pubitemid 27114163)
25. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, Gauntt CJ, Liu PP, Virology 2000 271 99 108 10.1006/viro.2000.0324 10814575 (Pubitemid 30341519)
26. A decay accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus ± adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. Shafren DR, Williams DT, Barry RD, J Virol 1997 71 9844 9848 9371658 (Pubitemid 27492441)
27. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. Fricks CE, Hogle JM, J Virol 1990 64 1934 1945 2157861 (Pubitemid 20148434)
28. Interaction with Coxsackievirus and Adenovirus Receptor, but Not with Decay-Accelerating Factor (DAF), Induces A-Particle Formation in a DAF-Binding Coxsackievirus B3 Isolate. Milstone AM, Petrella JE, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM, J Virol 2005 79 655 660 10.1128/JVI.79.1.655-660.2005 15596863 (Pubitemid 39648422)
29. A simple method for estimating fifty percent endpoints. Reed LJ, Muench M, Am J Hyg 1938 27 493 497
30. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. Oberste MS, Nix WA, Maher K, Pallansch MA, J Clin Virol 2003 26 3 375 377 10.1016/S1386-6532(03)00004-0 12637088 (Pubitemid 36294116)
31. Typing of human enterovirus by partial sequencing of VP2. Nasri D, Bouslama L, Omar S, Saoudin H, Bourlet T, Aouni M, Pozzetto B, Pillet S, J Clin Microbiol 2007 45 8 2370 2379 10.1128/JCM.00093-07 17537940 (Pubitemid 47295461)
32. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Thompson JD, Higgins DG, Gibson TJ, Nucleic Acids Res 1994 22 4673 4680 10.1093/nar/22.22.4673 7984417 (Pubitemid 24354800)
33. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor. Martino TA, Petric M, Brown M, Aitken K, Gauntt CJ, Richardson CD, Chow LH, Liu PP, Virology 1998 244 302 314 10.1006/viro.1998.9122 9601501 (Pubitemid 28384095)
34. Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor. Pan J, Narayanan B, Shah S, Yoder JD, Cifuente JO, Hafenstein S, Bergelson JM, J Virol 2011 85 7436 7443 10.1128/JVI.00503-11 21561916
35. Physical association of moesin and CD46 as a receptor complex for measles virus. Schneider-Schaulies J, Dunster LM, Schwartz-Albiez R, Krohne G, ter Meulen V, J Virol 1995 69 2248 2256 7884872
36. GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. Triantafilou K, Fradelizi D, Wilson K, Triantafilou M, J Virol 2002 76 633 643 10.1128/JVI.76.2.633-643.2002 11752154 (Pubitemid 34033362)
37. The coxsackievirus and adenovirus receptor. Freimuth P, Philipson L, Carson SD, Curr Top Microbiol Immunol 2008 323 67 87 18357766
38. Virus-Induced Abl and Fyn Kinase Signals Permit Coxsackievirus Entry through Epithelial Tight Junctions. Coyne CB, Bergelson JM, Cell 2006 124 119 131 10.1016/j.cell.2005.10.035 16413486 (Pubitemid 43069314)
39. Natural recombination event within the capsid genomic region leading to a chimeric strain of human enterovirus B. Bouslama L, Nasri D, Chollet L, Belguith K, Bourlet T, Bouslama L, Nasri D, Chollet L, Belguith K, Bourlet T, Aouni M, Pozzetto B, Pillet S, J Virol 2007 81 8944 8952 10.1128/JVI.00180-07 17537864 (Pubitemid 47311438)
40. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3. Pasch A, Küpper JH, Wolde A, Kandolf R, Selinka HC, J Gen Virol 1999 80 3153 3158 10567646
41. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. Zautner AE, Korner U, Henke A, Badorff C, Schmidtke M, J Virol 2003 77 18 10071 10077 10.1128/JVI.77.18.10071-10077. 2003 12941917 (Pubitemid 37122088)
42. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM, J Virol 1996 70 5282 5287 8764038 (Pubitemid 26240701)
43. Echoviruses bind heparan sulfate at the cell surface. Goodfellow IG, Sioofy AB, Powell RM, Evans DJ, J Virol 2001 75 4918 4921 10.1128/JVI.75.10. 4918-4921.2001 11312365 (Pubitemid 32381536)
44. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Lindberg AM, Crowell RL, Zell R, Kandolf R, Pettersson U, Virus Res 1992 24 187 196 10.1016/0168-1702(92)90006-U 1326828
45. Mapping of antigenic sites of coxsackievirus B3 by synthetic peptides. Auvinen P, Makela MJ, Roivainen M, Kallajoki M, Vainionpaa R, Hyypia T, APMIS 1993 101 517 528 10.1111/j.1699-0463.1993.tb00141.x 7691097 (Pubitemid 23280025)
46. The structure of coxsackievirus B3 at 3.5 Å resolution. Muckelbauer JK, Kremer M, Minor P, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossmann MG, Structure 1999 53 653 667